For eleven years, HC Partners declined every pediatric oncology RFP that crossed the desk. Not for lack of operational capability. For lack of investigator footprint.
In February 2026, a midsize biotech customer asked HC to bid on a global phase 2 pediatric program. HC did not staff up. It did not acquire. It rented the footprint. Six business days later, the feasibility team held 418 pediatric oncology investigators across 17 countries.
The bid defense ran 38 minutes. The award closed at €3.2M. HC's growth strategy, its CEO said, used to be constrained by the scale of their site relations. It is now constrained by their operational ambitions.
See how Lindus Health used Yendou’s site engagement platform to double bid throughput in 12 weeks and achieve some more:
🍊 394% increase in qualified sites🍊 15× more investigators onboarded🍊 6+ hours saved per FTE weekly🍊 12× more data points captured per site"
18 APRIL 2025
11 APRIL 2025
1
2
The Next Era of Clinical Operations Requires a New Kind of Site Engagement
